These results suggest that the Phase II CR program does not accelerate myocardial remodeling and our 2-wek hospitalized Phase II Cr program contributes not only to maintaining insulin sensitivity but, also, to improving the management of other cardiac risk factors.
Anglicky
These results suggest that the Phase II CR program does not accelerate myocardial remodeling and our 2-wek hospitalized Phase II Cr program contributes not only to maintaining insulin sensitivity but, also, to improving the management of other cardiac risk factors.